Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBellway Regulatory News (BWY)

Share Price Information for Bellway (BWY)

Share Price is delayed by 15 minutes
Get Live Data
1,828.00    -26.00 (-1.40%)
Bid:
1,827.00
Ask:
1,829.00
Spread: 2.00 (0.109%)
Market Cap: £2.07b
BWY Live PriceLast checked at - London Stock Exchange

Intraday Bellway Share Chart

Director/PDMR Shareholding

14 May 2026 09:50

RNS Number : 3489E
Bellway PLC
14 May 2026
 

BELLWAY p.l.c.

(the 'Company')

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND

PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

14 MAY 2026

 

Grant of options under the Company's Savings Related Share Option Scheme (the 'SRSOS')

 

The Company announces that, following the issue of an invitation to all eligible employees to participate in the Company's HMRC approved SRSOS, Shane Doherty, Chief Financial Officer of the Company has been granted options over ordinary shares of 12.5 pence each in the Company under the SRSOS on 13 May 2026 as follows:

 

 

Number of Options

Option Price

Exercise Period

Shane Doherty

1,911

£15.98

1 July 2031 to 31 December 2031

 

As part of this transaction, Shane Doherty cancelled his previous SRSOS options granted on the 28 November 2025, which was announced to the stock exchange on the 1 December 2025.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulations.

 

BELLWAY p.l.c.

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND

PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

Shane Doherty

2

 

Reason for the notification

 

a)

 

Position/status

 

Director (PDMR)

b)

 

Initial notification/Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Bellway p.l.c.

b)

 

LEI

 

213800CY4L3HST4FGZ98

4

 

Details of the transaction(s): section to date; to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

12.5p ordinary shares

 

GB0000904986

 

b)

 

Nature of the transaction

Grant of option under the Company's Sharesave Scheme.

c)

 

Price(s) and volume(s)

 

Price(s) Volume(s)

£15.98 1,911

d)

 

Aggregated information

 

Aggregated volume

Price

 

 

N/A

N/A

e)

 

Date of the transaction

 

13 May 2026

f)

 

Place of the transaction

 

Outside a Trading Venue

 

Name of contact and telephone number for queries:

Phil Hope

Group Finance Director and Company Secretary

Bellway p.l.c.

Tel: 0191 217 0717

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGMKRDRGVZG
Date   Source Headline
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:05 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNS2025 Annual Report and Accounts and Notice of AGM
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20259:52 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:05 amRNSLaunch of £150 million Share Buyback
14th Oct 20257:00 amRNSFull Year Results
2nd Oct 20254:04 pmRNSHolding(s) in Company
2nd Oct 20254:02 pmRNSHolding(s) in Company
1st Oct 20253:46 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
12th Aug 20257:05 amRNSNew Director and change of Company Secretary
12th Aug 20257:00 amRNSTrading Update
1st Aug 20252:16 pmRNSTotal Voting Rights
21st Jul 202511:12 amRNSDirector Declaration
9th Jul 20257:29 amRNSCMA Consults on Proposed Housebuilder Commitments
3rd Jul 202510:36 amRNSTotal Voting Rights
10th Jun 20257:00 amRNSTrading Update
5th Jun 20259:53 amRNSBlock listing Interim Review
2nd Jun 20253:19 pmRNSTotal Voting Rights
1st May 202511:35 amRNSTotal Voting Rights
9th Apr 20253:44 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202510:29 amRNSTotal Voting Rights
25th Mar 20257:00 amRNSInterim Results Announcement
3rd Mar 20259:23 amRNSTotal Voting Rights
21st Feb 20254:46 pmRNSDirector Declaration
19th Feb 202511:49 amRNSHolding(s) in Company
11th Feb 20257:00 amRNSTrading Update
3rd Feb 202510:20 amRNSTotal Voting Rights
14th Jan 20254:12 pmRNSHolding(s) in Company
2nd Jan 202510:08 amRNSTotal Voting Rights
18th Dec 20243:04 pmRNSDirector/PDMR Shareholding
12th Dec 20242:38 pmRNSResult of AGM
3rd Dec 202412:52 pmRNSBlock listing Interim Review
2nd Dec 202410:09 amRNSTotal Voting Rights
27th Nov 202410:37 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNS2024 Annual Report and Accounts and Notice of AGM
7th Nov 202411:00 amRNSHolding(s) in Company
1st Nov 20249:01 amRNSTotal Voting Rights
1st Nov 20248:16 amRNSHolding(s) in Company
25th Oct 202411:34 amRNSHolding(s) in Company
25th Oct 202410:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.